Skip to main content

Advertisement

Table 3 Frequency of patients who discussed each decision box topic in each participating primary healthcare clinic

From: Feasibility of a randomized controlled trial to evaluate the impact of decision boxes on shared decision-making processes

Decision box clinical topics (abbreviations) Clinics Number patients % patient (n = 37)
  1 2 3 4   
Statins for primary prevention of cardiovascular disease (Statins) 0 1 7 3 11 30
The fecal occult blood test to screen for colorectal cancer (FOBT) 2 0 6 0 8 22
Bisphosphonates to prevent osteoporotic fractures in postmenopausal women (OSTEO) 1 1 3 1 6 16
Acetylsalicylic acid for primary prevention of cardiovascular disease (ASA) 2 0 3 0 5 14
The BRCA1/2 gene mutation test to evaluate the risks of breast and ovarian cancer (BRCA) 1 2 0 0 3 8
The serum integrated test to screen women for fetal trisomy 21 (Prenatal) 2 0 0 0 2 5
The prostate-specific antigen test to screen men for prostate cancer (PSA) 0 0 2 0 2 5
Cholinesterase inhibitors to reduce the symptoms of Alzheimer’s disease (ChEIs) 0 0 0 0 0 0